Allergy Archives - Page 5 of 9 - Hospital Healthcare EuropeHospital Healthcare Europe

This website is intended for healthcare professionals only.

Allergy

Results of landmark PALISADE trial published in New England Journal of Medicine

Results of landmark PALISADE trial published in New England Journal of Medicine

Test predicts outcomes of hay fever therapies

Test predicts outcomes of hay fever therapies

New EpiPen junior validation process mandated following ‘critical’ shortages in UK

New EpiPen junior validation process mandated following ‘critical’ shortages in UK

Initiative launched to improve people's understanding of eczema

Initiative launched to improve people’s understanding of eczema

NICE issues draft guidance not recommending dupilumab

NICE issues draft guidance not recommending dupilumab

Omalizumab recommended in global chronic urticaria guideline

Omalizumab recommended in global chronic urticaria guideline

Peanut allergy drug passes clinical trial

Peanut allergy drug passes clinical trial

Guideline for the management of nut allergy helps to define diagnostic pathways, including the role of specific IgE testing

Reslizumab recommended by NICE

Reslizumab recommended by NICE

Marketing authorisation for dupilumab in moderate to severe atopic dermatitis recommended

Marketing authorisation for dupilumab in moderate to severe atopic dermatitis recommended

Candidate metabolomic network for bladder cancer diagnostics

Candidate metabolomic network for bladder cancer diagnostics

New guidance on diagnosis and management of allergic and non-allergic rhinitis published

Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS

Certolizumab pegol (Cimzia®) AutoClicks® Prefilled Pen now available on NHS

Survey reveals true impact of severe asthma on people’s lives

Survey reveals true impact of severe asthma on people’s lives

Management of allergic rhinitis